Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Discovery of dibenzylbutane lignan LCA derivatives as potent anti-inflammatory agents
Zhen
Wang†
b,
Juan
Zhang†
b,
Conghao
Gai
a,
Jing
Wang
a,
Xiaobin
Zhuo
a,
Yan
Song
c,
Yan
Zou
a,
Peichao
Zhang
a,
Guige
Hou
d,
Qingguo
Meng
*b,
Qingjie
Zhao
*a and
Xiaoyun
Chai
*a
aDepartment of Organic Chemistry, School of Pharmacy, Naval Medical University, Shanghai 200433, China. E-mail: qjzhao_325@126.com; chaixy1207@163.com
bSchool of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Yantai University, Yantai 264005, China. E-mail: zhenwang0703@163.com; qinggmeng@163.com
cNavy Medical Center, Naval Medical University, Shanghai 200433, China
dSchool of Pharmacy, Binzhou Medical University, Yantai 264003, China
First published on 17th June 2024
Abstract
Correction for ‘Discovery of dibenzylbutane lignan LCA derivatives as potent anti-inflammatory agents’ by Zhen Wang et al., RSC Med. Chem., 2024, https://doi.org/10.1039/d4md00053f.
There was an error in the structural configuration of the compound LCA and its derivatives shown in Fig. 1 and Scheme 1.
Fig. 1 should appear as follows:
 | ||
| Fig. 1 Design of target compounds. | ||
Scheme 1 should appear as follows:
 | ||
| Scheme 1 Synthesis of target compounds. Reagents and conditions: (a) sulfuric acid, MeOH, reflux, 5 h; (b) H2, Pd/C, MeOH, rt, 10 h; (c) benzyl bromide, K2CO3, acetone, reflux, 5 h; (d) NaOH, MeOH, reflux, 3 h; (e) (S)-4-benzyloxazolidin-2-one, N,N-dicyclohexylcarbodiimide, 4-dimethylaminopyridine, CH2Cl2, rt, 12 h; (f) lithium diisopropylamide, iodobenzene diacetate, tetrahydrofuran, −78 °C, 2 h; (g) lithium hydroxide monohydrate, H2O2, tetrahydrofuran, H2O, 0 °C, 15 min, then rt, 12 h; (h) O-benzotriazole-N,N,N′,N′-tetramethyl-uronium-hexafluoro-phosphate, N,N-diisopropylethylamine, N,N-dimethylformamide, rt, 4 h; (i) H2, Pd/C, MeOH, rt, 3 h. | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
Footnote |
| † These authors contributed equally to this work. |
| This journal is © The Royal Society of Chemistry 2024 |